The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination regimen, the company said on Thursday, clearing the way for its return to the ...
NDTV Profit on MSN
Centre Clears First Set Of Projects Under Electronics Parts Scheme; Seven Firms To Invest Rs 5,532 Crore
Among the listed players, Kaynes Technology will invest about Rs 3,280 crore to set up plants in Chennai and Tuticorin for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback